Pressmeddelanden

iCoat Medicals pressmeddelanden är endast tillgängliga på engelska. Vid frågor, vänligen kontakta oss genom info@icoatmedical.com

19 september, 2023 08:00

iCoat Medical meddelar positiva resultat från fas 1/2a-studien ATMIRe vid njurtransplantation

15 augusti, 2023 08:00

ICOAT MEDICAL PUBLISHES INTERIM REPORT Q2 2023

16 maj, 2023 08:00

ICOAT MEDICAL PUBLISHES INTERIM REPORT Q1 2023

10 maj, 2023 17:35

iCoat Medical completes enrollment in First In Human study of TUM012 in kidney transplantation

20 april, 2023 16:30

COMMUNIQUÉ FROM ICOAT MEDICAL AB’S (PUBL) ANNUAL GENERAL MEETING 20 APRIL 2023

5 april, 2023 18:45

Carl Bjartmar appointed Chief Commercial Officer of iCoat Medical

24 mars, 2023 10:00

iCoat Medical publishes Annual Report 2022

23 mars, 2023 18:40

NOTICE OF ANNUAL GENERAL MEETING IN ICOAT MEDICAL AB (PUBL)

22 mars, 2023 18:00

ICOAT MEDICAL EXPANDS ITS PATENT PORTFOLIO

15 februari, 2023 12:00

ICOAT MEDICAL PUBLISHES INTERIM REPORT Q4 2022